REG - Genus - Director/PDMR Shareholding <Origin Href="QuoteRef">GNS.L</Origin>

GenusAnnouncement

01/03/2017 10:10

RNS Number : 2066Y
Genus PLC
01 March 2017
1 March 2017
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that today, in accordance with the terms of joining contained in his employment contract, Dr. Nate Zwald, Chief Operating Officer, Genus ABS Dairy, was granted contingent rights over 7,225 ordinary shares in Genus under an individual award agreement as follows: 3,613 and 3,612 ordinary shares with a normal vesting date of 5 January 2018 and 5 January 2019 respectively.
Subject to the terms of the individual award agreement and continued service, the award will vest on the normal vesting dates as specified above.
No consideration was paid for the grant of this award and no consideration is due in connection with the exercise of this award.
The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the individual award agreement made on 1 March 2017.
For further information please contact:
Genus:
Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100
1. 
Details of the person discharging managerial responsibilities / person closely associated
a. 
Name
Dr. Nate Zwald
2. 
Reason for the notification
a. 
Position/status
Chief Operating Officer, Genus ABS Dairy 
b. 
Initial notification
/Amendment
Initial notification
3. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. 
Name
Genus plc
b. 
LEI
54930022EOITNKSIGH56
4. 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. 
Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB0002074580
b. 
Nature of the transaction
Grant of contingent rights over 7,225 ordinary shares in Genus under an individual award agreement
c. 
Price(s) and volume(s)
Price(s)
Volume(s)
1. 0p
7,225
 
d. 
Aggregated information
 Aggregated volume
 Price
n/a
e. 
Date of the transaction
2017-03-01 
f. 
Place of the transaction
London Stock Exchange, Main Market (XLON)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHUARRRBWAORAR